Avinash Patel

Head of Exploratory Sciences
Avinash Patel

Avinash (Avi) leads Exploratory Sciences at Dewpoint, leveraging multi-dimensional big data to gain insights into condensate disease biology. He is currently leading Dewpoint’s metabolic disease therapeutic area driving new target discovery and validation.

As one of the first scientists to join Dewpoint, Avi has initiated and advanced ideas from concept to successful drug-discovery programs and partnerships. Avi is one of the pioneers in the field of condensate biology, having authored multiple seminal publications in the area. During his postdoctoral training with founder Tony Hyman, Avi authored several seminal publications that established the connection between biomolecular condensates and human diseases, specifically in neurodegeneration. Avi discovered that aberrant FUS condensates confer a risk for Amyotrophic Lateral Sclerosis (ALS) disease pathology. Another breakthrough discovery was the unappreciated role of ATP, as a hydrotrope and its role in regulating protein solubility and condensation in live cells.

Avi’s upbringing in India drives and inspires him to follow the concept of “Jugaad”—a flexible approach to problem-solving that uses limited resources in an innovative way. He enjoys experimenting with new ways of cooking, traveling, playing squash, gardening, and watching football.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science